-
Locked Data M_2_5_1
Number of individuals who received buprenorphine for treatment of OUD (outcome measure for HCS Hypothesis 3) -
Locked Data M_2_7_2
Number of individuals receiving methadone retained at least 180 days (Medicaid) -
Locked Data M_2_5_5
Number of individuals who received buprenorphine for treatment of OUD (Medicaid) -
Locked Data M_2_5_4
Number of individuals who received medication for the treatment of OUD (Medicaid) -
Locked Data M_2_5_2
Number of individuals who received methadone for treatment of OUD (Medicaid) -
Locked Data M_2_19
Number of individuals screened for substance use (alcohol, drug use) (Medicaid) -
Locked Data M_2_1_3
Number of drug overdose deaths involving any psychostimulant (including cocaine) -
Locked Data M_2_1_1
Number of drug overdose deaths involving any psychostimulant (excluding cocaine) -
Locked Data M_2_1_4
Number of drug overdose deaths involving any benzodiazepine -
Locked Data M_2_1_2
Number of drug overdose deaths involving cocaine -
Locked Data M_2_4
Number of individuals with opioid dependence or abuse (Medicaid) -
Locked Data M_2_15_1
Number of individuals with OUD who are screened for hepatitis C -
Locked Data M_2_15_2
Number of individuals with OUD who are diagnosed with hepatitis C -
Locked Data M_2_15_3
Number of individuals with OUD who are treated for hepatitis C -
Locked Data M_2_16
Number of newly diagnosed HIV cases -
Locked Data Population values for HCS data analysis
There is no description for this dataset
-
Locked Data M_2_12_1
Number of individuals linked to MOUD following opioid-related emergency department visit (Medicaid) -
Locked Data M_1
Number of opioid overdose deaths (outcome measure for HCS Hypothesis 1) -
Locked Data M_1_5
Number of opioid overdose deaths involving any opioid and any psychostimulant (including cocaine) -
Locked Data M_2_1
Number of drug overdose deaths